baber/WOPTO huggingface dataset:
Patent JP-3132182-B2 (JP)
IPC: H01G11/86
Filed: 1992-08-31
Granted: 2001-02-05
Abstract: PURPOSE:To provide an electric double layer capacitor in which a conductive layer can be preserved without dissolving into electrolyte and resistance can be decreased without sacrifice of bonding power between the conductive layer and a polarizable electrode or a current collector while stabilizing electrochemically. CONSTITUTION:The electric double layer capacitor comprises a separator 12 interposed between a pair of polarizable electrodes 11a, 11b, electrolyte impregnated into the pair of polarizable electrodes 11a, 11b and the separator 12, and carbon based conductive layers 16a, 16b provided between the pair of polarizable electrodes 11a, 11b and a current collector, i.e., a metal case 13 and a metal cover 15, wherein an acrylic acid resin-styrene copolymer is employed as the binder for the carbon based conductive layers 16a, 16b.
Patent JP-H0421636-B2 (JP)
IPC: B01D9/00
Filed: 1984-12-27
Abstract: A protected trigger usuable in initiating crystallisation of a supercooled salt solution comprises a thin metallic strip containing multiple openings. The strip is protected as by a peripheral frame and/or by a metallic coating.
Patent JP-4446412-B2 (JP)
IPC: B32B5/18
Filed: 1999-10-06
Granted: 2010-04-07
Abstract: A composite sheet having a first, foamed polycarbonate resin layer and a second, non-foamed polycarbonate resin layer provided on at least one surface of the first layer and having a melt tension of at least 2.45 cN at 250 DEG C.
Patent JP-4338242-B2 (JP)
IPC: G01N21/35
Filed: 1998-10-16
Granted: 2009-10-07
Abstract: A heart rate value determined from a first physiological signal that is acquired independently from a second physiological signal, is used to control a band pass filter for controllably bandpass filtering the second physiological signal. In a system having sensors for independently acquiring both electrocardiogram (ECG) and pulse oximetry (SpO2) signals, a heart rate value determined from the ECG signal is used to controllably bandpass filter the red and infrared SpO2 signals, thereby reducing the level of artifact signal in the SpO2 signals. <IMAGE>
Patent JP-3269721-B2 (JP)
IPC: H04W64/00
Filed: 1993-12-01
Granted: 2002-04-02
Abstract: PURPOSE:To easily recognize where a mobile terminal is even when the mobile terminal does not respond by storing the installation place information of a base station in the base station and transmitting the stored installation place information when the transmission request of the installation place information is detected. CONSTITUTION:The base station 100 is provided with an information storage part 104 for storing the installation place information of the base station 100. When the transmission request of the installation place information is detected by a transmission request detection means, the installation place information of the base station 100 stored in the information storage part 104 is transmitted by an information output means 105. The transmission request detection means is provided with a timer means 107 for measuring the duration of a call to the mobile terminal and a detection means 106 for detecting the transmission request when the time measured by the timer means 107 exceeds the presecribed time set beforehand. The approximately several seconds to several tens seconds is set in the timer means 107.
Patent JP-3927609-B2 (JP)
IPC: A23L27/10
Filed: 1994-12-16
Granted: 2007-06-13
Abstract: In order to protect a fatty substance against oxidation, it is brought into the presence of plant matter containing phenolic antioxidants, by mixing the plant matter and the fatty substance at high temperature, then the mixture is pressed and clarified to obtain a stabilised liquid grease containing the antioxidants. In the case where a food containing a fatty substance is to be protected, the stabilised grease is incorporated into the fatty phase of the foodstuff.
Patent JP-H084631-B2 (JP)
IPC: A61K51/00
Filed: 1992-12-02
Abstract: The technical field of the invention relates to: (1) certain photosensitive substances used with lasers for discovery and destruction of tumors; (2) methods of making the substances; (3) use of the substances; and (4) certain light-delivery equipment used with the substance. To obtain tumor-selective, photosensitizing substances useful in the localization of neoplastic tissue and treatment of abnormal neoplastic tissue such as tumors, one of two methods is used. In the first method, a hydrolyzed mixture of the products of reaction of hematoporphyrin with acetic acid and sulfuric acid is cycled through a microporous membrane system to exclude low molecular weight products. In the second method, drugs are synthesized or derived from other pyrrole compounds. Other photosensitizing materials may be combined with a carrier that enters undesirable tissues and cells of the reticular endothelial system such as macrophages. These photosensitizing materials: (1) must have a triplet energy state above 3.5 kilocalories per mole; (2) cannot be easily oxidized; and (3) not physically quench any required energy state. Preferably, this photosensitizing material should be lipophilic. The substance is injected into the patient, clears normal tissue and then neoplastic tissue is irradiated using lasers. Laser equipment includes a light conductor and transmitting head with light differing surface and feedback path for radiated light related to dosage.
Patent JP-H087516-B2 (JP)
IPC: G03G15/22
Filed: 1990-11-29
Abstract: PURPOSE:To improve the efficiency of image formation without making the size of a device large by developing an electrostatic latent image by toner, forming a main image by transferring the toner image on a recording paper and forming an auxiliary image by an auxiliary image forming mechanism disposed in a developing device. CONSTITUTION:The main image is formed on the recording paper 40 by using a photosensitive body by a main image forming mechanism 20. Simultaneously, the auxiliary image is formed on the paper 40 by the auxiliary image forming mechanism 30. The forming mechanism 30 is disposed in the developing device 23 which develops the main image by the toner. Besides, the toner in the developing device 23 is supplied on one of electrodes and passed through the toner passing hole 32 of a substrate 31 by an image information generation means. Then, the auxiliary image is formed on the photosensitive body 10 or the recording paper 40 where the main image is formed. Thus, the auxiliary image is formed on the recording paper together with the main image and the size of the device is prevented from being made large.
Patent JP-H0428451-B2 (JP)
IPC: B21D51/30
Filed: 1985-05-13
Abstract: A packaging container is closed by using a double seam 152 to secure over the container body 70 a cover 74 of smaller diameter than is usual, creating a radial space 104 around the cover chuck wall 122 into which the body sidewall 72 is deformed to form a neck 76. The cover is initially placed on the body to form a sealable interface 142 therebetween, this interface being preserved throughout the seaming process. The body and/or the cover may be of plastics or metal or a laminated material. In an aseptic packaging process, a primary seal is created at the interface 142 under sterile conditions, seaming subsequently being carried out under non-sterile conditions.
Patent JP-H0511996-B2 (JP)
IPC: A61M29/00
Filed: 1988-09-20
Abstract: A catheter for dilating stenotic lesions has an elongated body (I) with at least one lumen (12) extending therethrough. A tip (T), constructed of materials softer than the elongated body is attached to the distal end of the body. The tip segment has at least one lumen (14) passing therethrough which is in alignment with the lumen (12) in the elongated body. A guide is adapted to pass through the aligned lumens. A balloon (D) is connected to the distal segment of the elongated body over its outer periphery, thereby creating a balloon cavity (24) therebetween. At least one additional lumen (A) is provided in the elongated body in flow communication with the balloon cavity, for selective inflation and deflation thereof, with a contrast fluid.
Patent JP-3138770-B2 (JP)
IPC: A43B5/00
Filed: 1989-07-14
Granted: 2001-02-26
Abstract: A construction for a shoe (20), particularly an athletic shoe such as a running shoe, includes a sole (28) provided with at least one bulge having concavely rounded inner and outer surfaces (30, 31). The bulge may be located on a side of the shoe sole (28) at a location which substantially corresponds to the location of one of the essential structural support and propulsion elements of an intended wearer's foot when inside the shoe. The thickness of the bulge decreases gradually in at least one of an anterior or posterior direction to a lesser thickness, as viewed in a horizontal plane when the shoe sole (28) is in an upright, unloaded condition.
Patent JP-3664444-B2 (JP)
IPC: A61F2/16
Filed: 1993-09-29
Granted: 2005-06-29
Abstract: A deformable intraocular lens injection system comprising a lens injecting device and a lens cartridge. The lens injecting device comprises a tubular body provided with a side receiver and a movable plunger having a faceted tip configured to engage the deformable intraocular lens loaded in the lens cartridge without damaging the trailing haptic.
Patent JP-3030088-B2 (JP)
IPC: C07D263/16
Filed: 1993-10-28
Granted: 2000-04-10
Abstract: Taxane derivatives and a method of preparing taxane derivatives of formula (I):  are disclosed. In general formula (I), Ar represents an aryl radical; R represents a phenyl radical or a radical R5-O- in which R5 represents an alkyl, alkenyl, alkynyl, cycloalkyl, phenyl or saturated or unsaturated nitrogenous heterocylcyl radical, R1 and R2, which are identical or different, each represent a hydrogen atom or an alkyl, phenylalkyl, phenyl, alkoxyphenyl, or dialkoxyphenyl radical, or else R1 and R2 form, together with the carbon atom to which they are bonded, a ring having from 4 to 7 members; R3 represents an acetyl radical or a protecting group of the hydroxyl functional group; and R4 represents a protecting group of the hydroxyl functional group.
Patent JP-3357047-B2 (JP)
IPC: A61L29/14
Filed: 1991-06-17
Granted: 2002-12-16
Abstract: A medical instrument comprising an instrument core having alubricious coating when wet, said coating comprising a first layer in direct surface contact with said instrument core and formed from a dried aqueous emulsion of a water-insoluble latex polymer, and a second layer comprising a dried aqueous solution of a water-soluble hydrophilic polymer. <IMAGE>
Patent JP-2920785-B2 (JP)
IPC: G02B6/00
Filed: 1991-09-20
Granted: 1999-07-19
Abstract: PCT No. PCT/AU91/00436 Sec. 371 Date Apr. 29, 1993 Sec. 102(e) Date Apr. 29, 1993 PCT Filed Sep. 20, 1991 PCT Pub. No. WO92/05535 PCT Pub. Date Apr. 2, 1992.An edgelit illuminated display system has a transparent medium having first and second opposing surfaces and at least one edge operable with a light source for illuminating the first and second surfaces. A matrix of dots on each of the surfaces is arranged to allow interaction of light between the surfaces. The matrix of dots on at least one of the surfaces substantially covers the entire surface for providing an even increased illumination throughout the surface, wherein when a graphic image is supported over the surface the graphic image is evenly illuminated.
Patent JP-2846115-B2 (JP)
IPC: B63B21/20
Filed: 1991-11-05
Granted: 1999-01-13
Abstract: PCT No. PCT/NO91/00137 Sec. 371 Date Apr. 27, 1993 Sec. 102(e) Date Apr. 27, 1993 PCT Filed Nov. 5, 1991 PCT Pub. No. WO92/07789 PCT Pub. Date May 14, 1992.The lifting apparatus employs a plurality of stacked annular discs, each of which is secured at the inner and outer periphery to an adjacent disc to define a hollow space. Circular discs are secured at the opposite ends of the stacked annular discs to enclose the hollow space. The lifting apparatus is collapsible from an extended elongated position to a collapsed position. A nipple is provided to permit the entry of compressed air into the hollow space when the lifting apparatus is in the elongated extended position to allow the hollow space to be radially expanded while being longitudinally contracted in order to effect lifting of an object secured to the lower end of the listing apparatus.
Patent JP-4507282-B2 (JP)
IPC: F01N13/02
Filed: 1995-09-12
Granted: 2010-07-21
Abstract: A stable, close-coupled catalyst, an article comprising the close-coupled catalyst and a related method of operation. The close-coupled catalyst comprises a catalyst support and a palladium catalytic component. Preferably and optionally, there are stabilizers including alkaline metal oxide, and rare earth metal components selected from the neodymium and lanthanum components. The close-coupled catalyst composition includes substantially no additional oxygen storage component such as praseodymium or cerium compounds. There is preferably a catalyst such as a three-way catalyst downstream of the close-coupled catalyst. The downstream catalyst preferably includes an oxygen storage component such as cerium oxide or praseodymium oxide.
Patent JP-3300346-B2 (JP)
IPC: A61G5/02
Filed: 1991-10-22
Granted: 2002-07-08
Abstract: PCT No. PCT/AU91/00487 Sec. 371 Date Jun. 21, 1993 Sec. 102(e) Date Jun. 21, 1993 PCT Filed Oct. 22, 1991 PCT Pub. No. WO92/06622 PCT Pub. Date Apr. 30, 1992.A back support for supporting the back of a seated person, comprising a concave shell having sides extending forwardly of the shell and straps extending between the sides to define a back support surface, the straps being of adjustable length between the sides, the arrangement being such that tension applied to the strap means causes the shell to deform whereby the back support surface conforms to the specific shape of the person's back.
Patent JP-3679807-B2 (JP)
IPC: B09C1/00
Filed: 1994-12-27
Granted: 2005-08-03
Abstract: A composition for treatment of water and soils comprises componentsA. CaCO3,B. at least one compound selected from the group consisting of calcium salts, including CaCl2 and Ca(NO3)2, and inorganic magnesium compounds,C. at least one compound selected from the group consisting of NaHCO3 and KHCO3,wherein the components A and B are present in a molar ratio of from 0.1:1 to 1:1, and wherein the components B and C are present in a molar ratio of from 1:3 to 1:1.
Patent JP-4082715-B2 (JP)
IPC: B67D1/07
Filed: 1997-12-17
Granted: 2008-04-30
Abstract: A valve ring (2) is used in a double valve (1) for a pressure container (4) serving for distributing a liquid, e.g. beer, under pressure of a gas, e.g. CO<2>. In open condition, the double valve has a gas passage (7) between a valve seat (8) in the valve and a valve face (9) in the valve ring, and a liquid passage (10) between a valve plug (11) and a valve-ring seat (12) in the centre opening (13) of the valve ring. The valve can be closed partly by pushing the valve face of the valve ring to abut on the valve seat under the influence of a first compression spring, partly by pushing the valve plug to abut on the valve-ring seat under the influence of a second compression spring. The valve ring comprises an elastomeric first ring (25) and a solid second ring (26) fixed on the outside of first ring along a part of the surface of this ring. The connection between the two rings is made sure by a purely mechanical engagement which, contrary to conventional valve ring surface joinings, is indifferent to the strong chemicals and high temperatures used in cleaning the container and its valve between each casking.
Patent ES-2368314-B2 (ES)
Title: Proceso para capturar isonitrilos.
Inventor: SOTELO PEREZ EDDY
IPC: C07C303/32
Filed: 2010-10-13
Granted: 2012-04-27
Abstract: Proceso para capturar isonitrilos. Estos sistemas son de utilidad en la síntesis de compuestos orgánicos, industria química y farmacéutica, o en procesos químicos respetuosos con el medio ambiente característicos de la Química Verde.
Patent ES-2425138-B2 (ES)
Title: Celda de ablación criogénica con  control de la temperatura de la muestra
Inventor: FERNANDEZ GARCIA BEATRIZ
IPC: G01N27/62
Filed: 2013-06-07
Granted: 2014-06-10
Abstract: Celda de ablación criogénica con control de la temperatura de la muestra (5) que comprende una tapa superior extraíble (2) con una ventana transparente al láser (3) y una base de la celda (4) con un sistema de refrigeración interno (12). El sistema también comprende un sistema de refrigeración externo (16), un sensor de temperatura (21), unos medios de control de la temperatura (22) y un sistema de ventilación externo (27). La celda se puede usar en combinación con otros dispositivos como, por ejemplo, un sistema de ablación láser acoplado a un sistema de plasma de acoplamiento inductivo con detección por espectrometría de emisión óptica o de masas.#De aplicación en aquellos sectores en los que se diseñen, produzcan o utilicen celdas de ablación, como por ejemplo el de la maquinaria y equipo mecánico, geología, biología, medicina, arqueología o química.
Patent AU-2001286333-B2 (AU)
Title: Method and arrangement for defrosting a vapor compression system
Inventor: HAFNER ARMIN
IPC: F25B9/00
Filed: 2001-08-31
Granted: 2006-08-31
Abstract: A method of defrosting of a heat exchanger (evaporator) in a vapor compression system including, downstream of a heat exchanger (evaporator) ( 3 ) to be defrosted, at least a compressor ( 1 ), a second heat exchanger (condenser/heat rejecter) ( 2 ), and an expansion device ( 6 ) connected by conduits in an operable manner to form an integral closed circuit. The heat exchanger ( 3 ) to be defrosted is subjected to essentially the same pressure as the compressor's ( 1 ) discharge pressure. Thus, the heat exchanger ( 3 ) is defrosted as the high-pressure discharge gas from the compressor ( 1 ) flows through to the heat exchanger, giving off heat to the heat exchanger ( 3 ). In the circuit, in connection with the expansion device ( 6 ) a first bypass loop 23 with a first valve ( 16 '), is provided. A pressure reducing device ( 6 ') is provided in a second bypass loop in conjunction with a second valve ( 16 ''') disposed downstream of the heat exchanger ( 3 ) being defrosted, whereby the first valve ( 16 ') is open and the second valve ( 16 ''') is closed when defrosting takes place.
Patent AU-2002213464-B2 (AU)
Title: Collapsible flotation device
Inventor: ARIAS DAVID A
IPC: A47C17/02
Filed: 2001-10-10
Granted: 2006-04-13
Abstract: A device comprises a spring and a sleeve. The spring is configured to form a closed loop. The spring is moveable between a coiled configuration when the spring is collapsed and an uncoiled configuration when the spring is expanded. The spring defines a circumference while in the uncoiled configuration. The spring is disposed within the sleeve.
Patent AU-2002234942-B2 (AU)
Title: Aminoketone asymmetric reductase and nucleic acid thereof
Inventor: SAKAMOTO KEIJI
IPC: C12N1/21
Filed: 2002-03-01
Granted: 2005-03-24
Abstract: A protein, which is an aminoketone asymmetric reductase, having an effect of producing d-pseudoephedrine by acting on l-2-methylaminopropiophenone, and having the following physiochemical properties:  substrate: l-2-methylaminopropiophenone optimum pH: pH 8.1 optimum temperature: 55 DEG C coenzyme: NADP molecular weight: about 28500 Da homotetramer  and a nucleic acid coding the protein.
Patent AU-2002314626-B2 (AU)
Title: Methods for binding AcmA-type protein anchor fusions to cell-wall material of micro-organisms
Inventor: KUIPERS OSCAR PAUL
IPC: C07K14/335
Filed: 2002-06-11
Granted: 2008-01-03
Abstract: Methods for improving binding of a proteinaceous substance to cell-wall material of a Gram-positive bacterium are disclosed. The proteinaceous substance includes an AcmA cell-wall binding domain, homolog or functional derivative thereof. The method includes treating the cell-wall material with a solution capable of removing a cell-wall component such as a protein, lipoteichoic acid or carbohydrate from the cell-wall material and contacting the proteinaceous substance with the cell-wall material.
Patent AU-2003222557-B2 (AU)
Title: A system and a method for modification of a device and a device suitable for modification
Inventor: HIMBERT HANS
IPC: A61M5/178
Filed: 2003-04-11
Granted: 2008-11-20
Abstract: A system and a method for modification of an manually operated injection device. The injection device comprises a housing (1-3) designed or suitable for manual gripping, a container for a preparation attached to (6) or enclosed in the housing, an outlet (4) for the preparation exposed with respect to the housing, optionally a cap or guard (8) arranged for removable attachment over the outlet and a mechanism arranged for moving the preparation at least from the container through the outlet. The system comprises a set of at least two elements (11, 11') having different properties in at least one respect. The elements (11, 11') are designed for mechanical attachment to one and the same area part (3) of the housing, one at the time. The method includes the steps of providing at least two elements (11, 11') having different properties in at least one respect, the elements being designed for mechanical attachment to one and the same area part (3) of the housing (1-3), one at the time, selecting one element (11) from the set, and attaching mechanically the selected element (11) to said area part (3) of the housing (1-3).
Patent AU-2003260786-B2 (AU)
Title: In vitro peptide expression libraray
Inventor: ELDRIDGE BILL
IPC: C07K1/14
Filed: 2003-09-05
Granted: 2008-03-13
Abstract: The invention provides a method for making  in vitro  peptide expression libraries, and for the isolation of nucleotide sequences encoding peptides of interest, wherein the peptides or proteins are specifically associated with the DNA encoding them through non-covalent protein: DNA binding. The method describes ways of making the library itself, DNA molecules encoding the library and uses of the expression library.
Patent AU-2003261943-B2 (AU)
Title: Method of diagnosing cancer by detecting GPC3
Inventor: OHIZUMI IWAO
IPC: G01N33/574
Filed: 2003-09-04
Granted: 2009-07-23
Abstract: Provided is a method for diagnosing cancer by detecting a novel cancer marker. Cancer can be diagnosed by detecting soluble glypican 3 in a test sample.
Patent AU-2003295742-B2 (AU)
Title: Coating composition curable with ultraviolet radiation
Inventor: KEMPF HANS
IPC: C08F2/48
Filed: 2003-11-18
Granted: 2009-09-17
Abstract: A UV radiation curable primer coating composition curable under a UV radiation emitting lamp or sunlight. The coating demonstrates improved curing time and includes ethylenically unsaturated free radically polymerizable compounds and 0.1% photoinitiator or less.
Patent AU-2004247085-B2 (AU)
Title: Intradermal needle
Inventor: LAIOSA JOHN
IPC: A61M5/32
Filed: 2004-06-03
Granted: 2010-04-08
Abstract: An intradermal needle comprising a needle cannula assembly having a limiter portion, a hub portion and a needle cannula, a protective cap having a forward and rearward cap to protect and shield a needle cannula prior to and after use, and means for engaging the needle cannula assembly and the rearward cap after use. The mated forward and rearward cap provide a sterile enclosure for the needle cannula assembly prior to use. Removing the rearward cap permits the needle cannula assembly to be coupled to a drug delivery device, while the forward cap removably shields the needle cannula. Removing the forward cap then exposes the needle cannula for use. After use, the distal end of the needle cannula assembly is placed into the rearward cap and lockingly engaged therewith.
Patent AU-2004275567-B2 (AU)
Title: Therapeutic treatment
Inventor: MEHTA JAY LAL
IPC: A61K31/505
Filed: 2004-09-22
Granted: 2008-01-10
Abstract: A combination comprising candesartan and rosuvastatin for the prevention or treatment of arteriosclerosis and for the prevention of cardiovascular events is described.